FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ... Read More The post Health Check: Telix jumps first hurdle with its ...

A stage 4 prostate cancer survivor shares his story of positivity and gratitude. After doing some yard landscaping, I began to have some rather severe back pain and muscle spasms. My first thought was ...

The former president announced last year he has an aggressive form of prostate cancer. He and his aides say he’s doing well ...

Joe Biden continues radiation therapy for Stage 4 prostate cancer that has metastasized to bone, with aides saying the ...

A tumor is an abnormal mass of tissue that forms when cells grow and divide more than they should, or do not die when they should. Tumors may be benign ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

For patients with mCRPC with bone metastases, the addition of radium-223 to enzalutamide therapy is associated with improved overall survival.

Former President Joe Biden made a rare public appearance at the Friday, March 6, funeral for Jesse Jackson amid his cancer battle. Biden, 83, attended the ceremony for the civil rights activist — who ...

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agentcombines thediagnostic performance of PYLARIFY® (piflufolastat F 18) ...